Sponsor Pipeline

Lixiaoling Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07387874 A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors Recurrent or Metastatic Solid Tumors Active, Not Recruiting
Get alerts when Lixiaoling's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free